Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Dirix

Showing results (161-170 of 195) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumoursP B Vermeulen, G Gasparini, S B Fox, et al.
British Journal of Cancer|December 25, 2013
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypesD J E Peeters, P-J van Dam, G G M Van den Eynden, et al.
Oncology Reports|December 3, 2011
A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancerX B Trinh, L Sas, S J Van Laere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantificationIlse Van der Auwera, Steven J Van Laere, Gert G Van den Eynden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapseM Brada, K Hoang-Xuan, R Rampling, et al.
British Journal of Cancer|October 9, 2008
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotypeI Van der Auwera, S J Van Laere, S M Van den Bosch, et al.
Clinical Breast Cancer|April 24, 2002
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized studyM Kaufmann, E Bajetta, L Y Dirix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2010
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatmentS Dawood, S D Merajver, P Viens, et al.
British Journal of Cancer|March 9, 2013
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sortingD J E Peeters, B De Laere, G G Van den Eynden, et al.
Investigational New Drugs|April 14, 2021
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumorsGerald S Falchook, Marc Peeters, Sylvie Rottey, et al.
Pageof 20

Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumoursP B Vermeulen, G Gasparini, S B Fox, et al.
British Journal of Cancer|December 25, 2013
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypesD J E Peeters, P-J van Dam, G G M Van den Eynden, et al.
Oncology Reports|December 3, 2011
A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancerX B Trinh, L Sas, S J Van Laere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantificationIlse Van der Auwera, Steven J Van Laere, Gert G Van den Eynden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapseM Brada, K Hoang-Xuan, R Rampling, et al.
British Journal of Cancer|October 9, 2008
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotypeI Van der Auwera, S J Van Laere, S M Van den Bosch, et al.
Clinical Breast Cancer|April 24, 2002
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized studyM Kaufmann, E Bajetta, L Y Dirix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2010
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatmentS Dawood, S D Merajver, P Viens, et al.
British Journal of Cancer|March 9, 2013
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sortingD J E Peeters, B De Laere, G G Van den Eynden, et al.
Investigational New Drugs|April 14, 2021
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumorsGerald S Falchook, Marc Peeters, Sylvie Rottey, et al.
Pageof 20